“Workforce optimization” is the watchword at Baton Rouge, La.-based Amedisys Inc. (NASDAQ: AMED). The company seeks to build clinical capacity to support its long-term expansion, expecting to achieve growth at a higher rate than a projected 7% to 8% for the overall hospice market, according to President and COO Chris Gerard. With labor pressures the […]
Last month, connectRN announced it had raised $76 million, with the Series F round, led by Suvretta Capital Management and Avidity Partners, with other investors including Amedisys Inc. (Nasdaq: AMED). Amedisys did not disclose the size of its investment in connectRN, which has now raised more than $95 million since its 2014 founding. Along with […]
By continuing to use the site, you agree to the use of cookies. more information
The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.
